Tucker M. FDA Approves Continuous Glucose Monitor for Children. Available at http://www.medscape.com/viewarticle/820154. Accessed: February 17, 2014.
FDA expands indication for continuous glucose monitoring system, first to replace fingerstick testing for diabetes treatment decisions. FDA.gov. Available at https://www.fda.gov/news-events/press-announcements/fda-expands-indication-continuous-glucose-monitoring-system-first-replace-fingerstick-testing. December 20, 2016; Accessed: November 14, 2019.
Pleus S, Baumstark A, Jendrike N, Mende J, Link M, Zschornack E, et al. System accuracy evaluation of 18 CE-marked current-generation blood glucose monitoring systems based on EN ISO 15197:2015. BMJ Open Diabetes Res Care. 2020 Jan. 8 (1):[Medline].
Le LV, Chendke GS, Gamsey S, Wisniewski N, Desai TA. Near-Infrared Optical Nanosensors for Continuous Detection of Glucose. J Diabetes Sci Technol. 2019 Nov 9. 1932296819886928. [Medline].
King F, Ahn D, Hsiao V, Porco T, Klonoff DC. A Review of Blood Glucose Monitor Accuracy. Diabetes Technol Ther. 2018 Dec. 20 (12):843-856. [Medline].
Ramljak S, Musholt PB, Schipper C, Flacke F, Sieber J, Borchert M. The precision study: examining the inter- and intra-assay variability of replicate measurements of BGStar, iBGStar and 12 other blood glucose monitors. Expert Opin Med Diagn. 2013 Nov. 7(6):511-6. [Medline].
Deiss D, Bolinder J, Riveline JP, Battelino T, Bosi E, Tubiana-Rufi N, et al. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care. 2006 Dec. 29(12):2730-2. [Medline].
Wentholt IM, Vollebregt MA, Hart AA, Hoekstra JB, DeVries JH. Comparison of a needle-type and a microdialysis continuous glucose monitor in type 1 diabetic patients. Diabetes Care. 2005 Dec. 28(12):2871-6. [Medline].
Battelino T, Phillip M. Real-time continuous glucose monitoring in randomized control trials. Pediatr Endocrinol Rev. 2010 Aug. 7 Suppl 3:401-4. [Medline].
Chaudhry T, Klonoff DC. SMBG out of control: the need for educating patients about control solution. Diabetes Educ. 2013 Sep-Oct. 39(5):689-95. [Medline].
Lane JE, Shivers JP, Zisser H. Continuous glucose monitors: current status and future developments. Curr Opin Endocrinol Diabetes Obes. 2013 Apr. 20(2):106-11. [Medline].
Mian Z, Hermayer KL, Jenkins A. Continuous Glucose Monitoring: Review of an Innovation in Diabetes Management. Am J Med Sci. 2019 Nov. 358 (5):332-339. [Medline].
Bode BW. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections. Clin Ther. 2007. 29 Suppl D:S135-44. [Medline].
DeWitt DE, Hirsch IB. Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review. JAMA. 2003 May 7. 289(17):2254-64. [Medline].
FDA Consumer Upate 2009 - Getting Up to Date on Glucose Meters. Available at http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm049051.htm.
FDA Consumer Update 3/21/2013 - Useful Tips to Increase Accuracy and Reduce Errors in Test Results from Glucose Meters. Available at http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/TipsandArticlesonDeviceSafety/ucm109519.htm.
FDA Consumer Update 3/23/2013- Common Problems with the Use of Glucose Meters at the Point of Care. Available at http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/TipsandArticlesonDeviceSafety/ucm109449.htm.
FDA Guidelines. Blood Glucose Monitoring Test Systems for Over-the-Counter Use. [Full Text].
FDA Guidelines. Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use. Jan 2014. [Full Text].
FDA Guidelines: Blood Glucose Monitoring Devices. Available at http://www.fda.gov/medicaldevices/productsandmedicalprocedures/invitrodiagnostics/glucosetestingdevices/default.htm. Accessed: June 2014.
Freckmann G, Baumstark A, Jendrike N, et al. System accuracy evaluation of 27 blood glucose monitoring systems according to DIN EN ISO 15197. Diabetes Technol Ther. 2010 Mar. 12(3):221-31. [Medline].
Hamaty M. Insulin treatment for type 2 diabetes: When to start, which to use. Cleve Clin J Med. 2011 May. 78(5):332-42. [Medline].
International Diabetes Federation. Guideline on Self-Monitoring of Blood Glucose in Non-Insulin Treated Type 2 Diabetes. [Full Text].
Klonoff DC, Buckingham B, Christiansen JS, Montori VM, Tamborlane WV, Vigersky RA, et al. Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011 Oct. 96(10):2968-79. [Medline]. [Full Text].
Practice Advisory Blood Glucose Meter Accuracy. Sept 16, 2013. [Full Text].
Standards of medical care in diabetes--2014. Diabetes Care. 2014 Jan. 37 Suppl 1:S14-80. [Medline]. [Full Text].
Steil GM, Rebrin K, Mastrototaro J, Bernaba B, Saad MF. Determination of plasma glucose during rapid glucose excursions with a subcutaneous glucose sensor. Diabetes Technol Ther. 2003. 5(1):27-31. [Medline].
Stolar MW. Defining and achieving treatment success in patients with type 2 diabetes mellitus. Mayo Clin Proc. 2010 Dec. 85(12 Suppl):S50-9. [Medline].
van Belle TL, Coppieters KT, von Herrath MG. Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev. 2011 Jan. 91(1):79-118. [Medline].
Wilhelm B, Forst S, Weber MM, Larbig M, Pfutzner A, Forst T. Evaluation of CGMS during rapid blood glucose changes in patients with type 1 diabetes. Diabetes Technol Ther. 2006 Apr. 8(2):146-55. [Medline].
